Skip to content

ARQT ARCUTIS BIOTHERAPEUTICS INC

Follow

COM (common), issuer CIK 1787306

207 managers (209 13F filers) reported a position in ARQT shares at 2024-12-31, 128,850,489 shares in all. 39 filers opened a position and 28 filers sold out during the quarter.

Managers
207
13F filers
209
New
39
Added
60
Reduced
65
Sold out
28
Shares held by filers
128,850,489

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q4 2024

Filers in the available 13F reports with a share position at 2024-12-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Parallel Advisors, LLC28$390<0.01%new13F-HRTimeline
Arax Advisory Partners26$363<0.01%-71813F-HRTimeline
US BANCORP \DE\in group US BANCORP \DE\24$334<0.01%new13F-HRTimelineGroup
CoreCap Advisors, LLC19$265<0.01%new13F-HRTimeline
IFP Advisors, Inc13$181<0.01%new13F-HRTimeline
Covestor Ltd10$00%+113F-HRTimelineValue filed as zero, left out of ratios.
CONCOURSE FINANCIAL GROUP SECURITIES, I…0$00%013F-HRTimelineValue filed as zero, left out of ratios. Amount filed as zero, left out of ratios.

Events

  • BlackRock, Inc. reported 17,751,435 ARQT shares, 14.1% of the class, as of 2026-09-30, in a 13G/A filed 2026-10-05. 0002012383-26-003314

    Accepted , ingested